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ABSTRACT
OBJECTIVE: To perform a cross-cultural adaptation of the Prenatal Diagnostic Procedures 
Anxiety Scale questionnaire for application in the Brazilian cultural context.
METHODS: The translation and back translation processes followed internationally 
accepted criteria. A committee of experts evaluated the semantic, idiomatic, experimental 
and conceptual equivalence, proposing a pre-final version that was applied in 10.0% of the 
final sample. Afterwards, the final version was approved for the psychometric analysis. At that 
stage, 55 pregnant women participated which responded to the proposed Brazilian version 
before taking an ultrasound examination at a public hospital in Santa Catarina, in the year of 
2017. The Edinburgh Postnatal Depression Scale was used as an external reliability parameter. 
The internal consistency of the instrument was obtained by Cronbach’s alpha. Validation was 
performed by exploratory factorial analysis with extraction of principal components by the 
Kaiser-Guttman method and Varimax rotation.
RESULTS: The Cronbach’s alpha value of the total instrument was 0.886, and only the percentage 
of variance from item 2 (0.183) was not significant. The Kaiser-Guttman criterion defined three 
factors responsible for explaining 78.5% of the variance, as well as the Scree plot. Extraction of 
the main components by the Varimax method presented values from 0.713 to 0.926, with only 
item 2 being allocated in the third component.
CONCLUSIONS: The Brazilian version is reliable and valid for use in the diagnosis of anxiety 
related to the performance of ultrasound procedures in prenatal care. Due to the lack of 
correlation with the rest of the construct, it is suggested that item 2 be removed from the 
final version.
DESCRIPTORS: Ultrasonography Prenatal, psychology. Test Anxiety Scale. Surveys and 
Questionnaires, utilization. Translations. Validation Studies. 
Correspondence: 
Lucas Kindermann 
Rua Adolfo Melo, 37 apto 601 
Centro 
88015-090 Florianópolis, SC, Brasil 
E-mail: lucas.kindermann@gmail.com
Received: Dec 14, 2017
Approved: Apr 10, 2018
How to cite: Kindermann L, 
Traebert J, RD Nunes. Validation 
of an anxiety scale for prenatal 
diagnostic procedures. Rev Saude 
Publica. 2019;53:18.
Copyright: This is an open-access 
article distributed under the 
terms of the Creative Commons 
Attribution License, which permits 
unrestricted use, distribution, and 
reproduction in any medium, 
provided that the original author 
and source are credited.
http://www.rsp.fsp.usp.br/
2Validation of prenatal anxiety scale Kindermann L et al.
https://doi.org/10.11606/S1518-8787.2019053000621
INTRODUCTION
Anxiety is a debilitating emotional state or condition with the potential to alter the quality 
of life1. In addition to being the most prevalent psychiatric disorder, it is associated with 
several conditions that compromise the development of pregnancy and the fetus, from 
negative neonatal consequences (such as prematurity, low birth weight, low Apgar scores, 
fetal development deficit) to lasting effects on the physical and psychological development 
of children, as well as obstetric complications such as vaginal bleeding and the threat of 
abortion2. About one-fifth of the world’s adult population has already suffered from some 
anxiety disorder at some point in their lives², with women being about 1.5 times more likely 
to develop them than men3. Brazil is the country with the highest rate of people with this 
type of disorder in the world. According to estimates by the World Health Organization, 
9.3% of Brazilians have some anxiety disorder4. During the period before delivery, 9 to 22% 
of women have any of them4,5.
Maternal emotional state during prenatal care is associated with numerous adverse 
effects. The mental health of the pregnant woman is a risk factor for anxiety and 
postnatal depression6,7. For the child, maternal disorder increases the risk of anxiety, 
depression, attention deficit, hyperactivity and cognitive deficits in extrauterine 
life8–15. It may also result in infants too small for gestational age16 due to the excess of 
cortisol released by the pregnant woman17, abnormalities in several fetal tissues, and 
prematurity, aside from probably being related to low response of the fetal adaptive 
immune system to vaccines, which would explain the increase in infectious and 
autoimmune disease rates17–19. In addition, anxiety symptoms during pregnancy are 
related to the behavior of children in the first months postpartum: children of anxious 
mothers are more likely to show negative emotions20. Women with high levels of prenatal 
anxiety in early pregnancy are more likely to choose not to breastfeed and incur into 
early cessation of exclusive breastfeeding21,22.
The association between anxiety and prenatal diagnostic procedures is common, seeking 
to provide information on fetal gestation and development23. Obstetric ultrasonography, 
although not invasive, increases anxiety in pregnant women because of the potential 
to indicate fetal changes24. In Brazil, Febrasgo (Federação Brasileira das Sociedades de 
Ginecologia e Obstetrícia) instituted the use of at least three ultrasonography exams during 
pregnancy: first trimester morphological ultrasound, between 11 and 14 weeks; second 
trimester morphological ultrasonography and cervical uterine examination between 20 
and 24 weeks; and obstetric ultrasonography between 34 and 36 gestation weeks25.
Several instruments are used to measure anxiety in women in the perinatal period, but only 
the Pregnancy Anxiety Scale26 was specifically designed for this use27. Nevertheless, none 
was developed to study anxiety prior to the conduction of diagnostic procedures, when 
concerns about fetal health and development are evident23.
Originated from a rigorous development process and from psychometric assessments, the 
Prenatal Diagnostic Procedures Anxiety Scale (PDPAS) is a tool that measures the patient’s 
fear and anxiety before undertaking a prenatal diagnosis procedure, based on self-reported 
answers about her emotions and thoughts about the procedure itself and its results23. The 
PDPAS was recently created and translated into several languages, but validated only for 
the Croatian population; it is a sensitive method that can be used in research and screening 
in clinical settings23.
The original version of the PDPAS was developed by Košec et al.23, from the gynecology and 
obstetrics department of the University Hospital Center Sisters of Mercy in Zagreb, Croatia. 
The PDPAS was elaborated based on the clinical experience of the authors in gynecology, 
obstetrics and psychology, and was designed to be used before some procedures such as 
amniocentesis and ultrasonography23.
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Currently, there is no validated instrument in Brazil that allows the evaluation of anxiety 
in these situations. This study aims to propose a Brazilian version and to observe its 
psychometric properties of reliability and construct validity. After adapting PDPAS to this 
cultural context, the Brazilian Portuguese version can be validated and used to measure the 
anxiety related to prenatal diagnostic procedures. It will also allow to widen the knowledge 
of health professionals and stimulate screening programs to avoid various complications for 
mothers and children. Therefore, the objective of this research is to cross-culturally adapt 
the PDPAS questionnaire for application in the Brazilian cultural context and to observe 
the psychometric properties of the proposed Brazilian version.
METHODS
The consent of the authors of the original instrument was obtained in order to conduct 
this study, as well as for all stages of the translation process. The study was performed at 
the gynecology and obstetrics service of the Hospital Regional de São José (HRSJ), located 
in the city of São José, state of Santa Catarina, in the year of 2017.
The study was composed of two stages: one to propose the Brazilian version of PDPAS, and 
the second to observe its psychometric properties of reliability and validity.
Step I - Proposal of the Brazilian Version of PDPAS
The guidelines for the process of cross-cultural adaptation are those recommended by 
Beaton et al.28 The direct translation of the PDPAS questionnaire from Croatian into 
Portuguese was carried out by two sworn translators, without medical knowledge, academic 
ties or knowledge of the purpose of the study. Both translations were compared and 
synthesized into a single version by the research authors. Based on this synthesis, a back-
translation was performed by a native Croatian speaker, without any medical knowledge 
or of the original questionnaire.
A committee of experts evaluated the semantic, idiomatic, experimental and conceptual 
equivalence of the Brazilian version at this stage. The committee was constituted by two 
Ph.D. professors with experience in epidemiology and nursing, a doctorate student in 
health sciences, and a medical student. After identifying and discussing discrepancies 
in the process of translation and back-translation, a pre-final version was proposed. The 
pre-final version was applied in six pregnant women before an ultrasonography, in order 
to identify difficulties regarding the understanding of the questions or the layout and the 
time required for response. After analyzing the results of the pre-final version, the final 
version was approved (Annex).
Step II - Evaluation of Psychometric Properties from the Brazilian Version of the PDPAS
A cross-sectional study was performed involving pregnant women awaiting obstetric 
ultrasonography scheduled at the gynecology and obstetrics service of the HRSJ, from March 
to June 2017. To calculate the sample size, a ratio of five pregnant women was used for each 
question, as recommended in the literature29. The total of 11 questions resulted in a sample of 
55 patients selected by simple sampling. Patients aged 18 years or more and who knew how to 
read and write in the Portuguese language were included. Patients with clinical and psychiatric 
disorders that prevented participation in data collection and patients with an already known 
obstetric pathology were excluded. Data collection occurred by applying the Brazilian version of 
the PDPAS before the examination. At the same time, demographic and obstetric characteristics 
of the patients under study were collected and the Edinburgh Postnatal Depression Scale (EPDS)30 
questionnaire translated and validated, in order to assess external reliability.
In the PDPAS, the interviewees are asked to score each item from 0 to 3, with 0 being “never 
or rarely” having thought about a certain subject, and 3 being “almost always or always” 
having thoughts about it. The scores are summed to achieve the final result, ranging from 
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zero to 33. The EDPS, in turn, is a 10-question questionnaire designed to identify women 
with postpartum depression. The items from the scale correspond to various symptoms of 
clinical depression such as: guilt, sleep disorder, low energy, anhedonia, and suicidal ideas. 
The overall rating is made by the total score, which is the sum of the points of the 10 items. 
Higher scores indicate more depressive symptoms. The EPDS can be used within eight weeks 
after delivery and can also be used to track depression during pregnancy.
External reliability, meaning the correlation between two different instruments that 
evaluate the same domain, was calculated by Pearson’s linear correlation and the intraclass 
correlation coefficient.
The psychometric property of internal consistency, a way to measure the correlation between 
different items of the same questionnaire, was obtained by Cronbach’s alpha coefficient.
The psychometric property of validity was measured by means of exploratory factor analysis 
(EFA) with main component extraction (MCE). In order to observe the adequacy of EFA 
in the data of this study, the following previous analyses were made: relation between the 
number of questions in the questionnaire and the number of subjects interviewed, analysis 
of the correlation matrix between each pair of questions by Pearson’s linear correlation, 
aside from the statistical tests Kaiser-Meyer-Olkin (KMO) and Bartlett’s sphericity29.
For the definition of the number of factors, the criterion of latent dimensions, namely the 
Kaiser-Guttman criterion, was used, as it takes into account only the factors corresponding to 
eigenvalues higher than one (λ ≥ 1) or very close to one. For such, the MCE method was used, 
which minimizes the correlation between factors, the first one being formed by the highest 
percentage of the variance shared by the questions of the questionnaire. The use of this method 
allowed to perform the structural reduction of the data, to define rankings of observations by 
using factors, and to verify the validity of the previously established constructs.
Factor loadings were represented by Pearson correlation between the questions and each 
one of the factors. Based on the Kaiser-Guttman criterion, the factor loadings between 
the factors corresponding to eigenvalues smaller than one as well as corresponding to the 
questions must be low. Thus, the questions that shared small variance percentages with 
the others had their factor loadings elevated by a single factor. Conceptually, the sum of the 
squares of the loadings for each question should always be equal to the unit if the number of 
factors extracted equals the number of questions. This kind of sum is called commonality, 
which represents the shared total variance of each question in all factors based on the 
pre-selected eigenvalues. Commonality analysis allowed to verify whether any question 
did not share a significant percentage of variance with the factors defined.
The Varimax rotation method was used to minimize the number of questions that presented 
high loads in a given factor through the redistribution of loads and maximization of the 
variance shared in factors corresponding to smaller eigenvalues.
All analyzes were performed by means of the application SPSS, version 18.0. The research 
project was submitted to and approved by the Research Ethics Council of UNISUL, under 
Certificate of Presentation for Ethical Appreciation 62242916.9.0000.5369.
RESULTS
The process of cross-cultural adaptation of the Croatian PDPAS instrument generated the 
version for the Brazilian Portuguese language (Annex).
For the cross-sectional study to observe its psychometric properties, 55 pregnant women were 
invited to participate. There was no withdrawal after the application of the questionnaires. 
The authors assumed the normal distribution of data, since in the psychometric evaluation 
process the analyses are performed between the same individuals.
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The age of the pregnant women ranged from 18 to 41 years. The majority (70.9%) was between 
20 and 35 years of age, Caucasian (72.7%), lived with partner (90.9%) and reported eight 
or more education years (67.3%). The gestational age of the participants at the time the 
questionnaire was applied ranged from 8 to 38 complete weeks of gestation, with average 
of 27±9 completed weeks. The obstetric characteristics of the patients evaluated are shown 
in Table 1.
At the moment of evaluation, the patients waited for transvaginal (9.1%), morphological 
(34.5%), morphological with transvaginal (7.3%) or obstetric (49.1%) ultrasound examinations.
Data analysis showed a variance of the PDPAS score from zero to 29, reaching an average 
of 13.3±7.8 points. The EPDS30 ranged from zero to 20, with an average of 8.8±5.0 points, 
while its anxiety subscale presented scores ranging from zero to 12, with an average of 
5.5±3.1 points.
The external reliability of the PDPAS was assessed by comparing it with the anxiety subscale 
from EPDS30, obtaining a Pearson correlation index of 0.404 (p = 0.002) and the intraclass 
correlation coefficient of R = 0.575 (95%CI 0.272–0.752).
The PDPAS internal consistency analysis determined a Cronbach’s alpha of 0.886. Cronbach’s 
alpha values, in case each of the questions was excluded, were similar to the total value for 
the 10 questions, except for question 2 (0.183) (Table 2).
The previous analysis of data suitability for EFA showed that the correlation matrix between 
the items presented significant results among the majority of crosses (p < 0.001), whereas 
Pearson correlation showed coefficients above 0.3. The KMO criterion for sample adequacy 
was 0.810, indicating a correlation between the variables. The Bartlett sphericity test also 
demonstrated suitability of the data for the EFA technique (p < 0.001). These measures 
showed that EFA could be performed. The communities showed that the percentage of 
explained variance of all items was higher than 50.0%.
Table 1. Obstetric characteristics of the study population. Hospital Regional de São José, state of Santa 
Catarina, Brazil, 2017. (n = 55)
Obstetric characteristics n %
Previous vaginal births
Yes 27 49.1
No 28 50.9
Previous Cesarean section
Yes 16 29.1
No 39 70.9
Previous abortions
Yes 13 23.6
No 42 76.4
Previous gestational disease
Yes 13 23.6
No 42 76.4
Previous fetal malformation
Yes 4 7.3
No 51 92.7
Previous neonatal death
Yes 5 9.1
No 50 90.9
Having performed ultrasonography in this gestation
Yes 51 92.7
No 4 7.3
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Kaiser-Guttman’s latent dimension criterion allowed for a reduction in the correlation 
between factors, defining three of them as responsible for explaining 78.5% of the total 
variance of the instrument for eigenvalues greater than or close to one. The eigenvalue 
results for the three major components are presented in Table 3. Likewise, the generated 
Scree plot demonstrated the factor groupings, with reduction in three main components 
at the point of inflection, according to the Figure.
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Figure. Scree plot. Hospital Regional de São José, state of Santa Catarina, Brasil, 2017. (n = 55)
Table 3. Total variance explained by the extraction method of principal component analysis from the 
Brazilian version of Prenatal Diagnostic Procedures Anxiety Scale. Hospital Regional de São José, state 
of Santa Catarina, Brazil, 2017. (n = 55)
Component
Extraction sum of squared loadings Rotation sum of squared loadings
Total % variance % cumulative Total % variance % cumulative
Component 1 5.410 49.186 49.186 4.098 37.251 37.251
Component 2 2.352 21.385 70.571 3.210 29.183 66.434
Component 3 0.869 7.896 78.468 1.324 12.033 78.468
Table 2. Reliability analysis by Cronbach’s alpha of the Brazilian version of the Prenatal Diagnostic 
Procedures Anxiety Scale (PDPAS). Hospital Regional de São José, state of Santa Catarina, Brazil, 2017. 
(n = 55)
Items from the Brazilian version of PDPAS
Correlation of 
total item if 
corrected
Cronbach 
Alpha if item 
is deleted
1 I am afraid that the procedure will harm the baby. 0.526 0.888
2 Baby certainly has anomalies. 0.183 0.903
3 I am worried about the procedure itself. 0.677 0.879
4 I am worried about the result of the procedure. 0.718 0.876
5 I am afraid of pain during the procedure. 0.473 0.891
6 I am afraid of discomfort during the procedure. 0.594 0.884
7 The waiting for the results makes me anxious. 0.764 0.873
8 The waiting for the procedure is upsetting itself. 0.782 0.871
9 I am afraid of miscarriage due to the procedure. 0.568 0.886
10 I am afraid there is something wrong with the baby. 0.694 0.878
11 I am anxious because I do not know what to do if the results are abnormal. 0.735 0.875
7Validation of prenatal anxiety scale Kindermann L et al.
https://doi.org/10.11606/S1518-8787.2019053000621
The extraction of the main components with the Varimax rotation method presented values 
ranging from 0.713 to 0.926, and only item 2 was allocated to the third component, as shown 
in Table 4. The overall adjustment of the EFA was performed without item 2, demonstrating 
a strengthening of the weights charged to the remaining items.
DISCUSSION
The cross-cultural adaptation process generated a Brazilian version of the PDPAS that was 
easy to apply before the ultrasound examinations in pregnant women. The application of the 
instrument to patients who performed amniocentesis was not possible due to the absence of 
this test in the routine of the service where this study was done, as it is uncommon in Brazil. 
In developed countries, especially where interruption of pregnancy is covered by local laws 
and culture, examination has much broader indications than those found in our setting.
External reliability was observed by the correlation between the Brazilian version of the 
PDPAS questionnaire and a subscale of the EPDS30 that presents a domain related to the 
evaluation of anxiety. The values found in the Pearson correlation analysis showed a weak 
correlation with the already validated instrument, but the intraclass correlation coefficient 
showed a satisfactory correlation between the two instruments. EPDS30 was originally 
developed to assess postnatal depression, but some of its items address anxiety, which 
allows this instrument to also be used for this domain.
The internal consistency, expressed by the Cronbach’s alpha of 0.886, reached a high level, 
higher than the value found in the validation of the original instrument in Croatian (0.800)23. 
Then, each item of the instrument was evaluated, resulting in a variance from 0.183 to 
0.782. Only item 2 presented low consistency on the set of questions, being outside the 
ideal standard. The removal of this question from the instrument changed the Cronbach’s 
alpha value to 0.903, which demonstrates low reliability of this item in the general context 
of the construct.
In the validity analysis from the Varimax rotation method, it was possible to observe which 
items were grouped in each of the components. The first one consisted of questions 3, 4, 7, 8, 
10 and 11; the second consisted of questions 1, 5, 6 and 9; the third consisted only of item 2. 
This grouping of items allowed to assess the domains that each component evaluated. Thus, 
the first component was related to anxiety and concern about the ultrasound procedure or 
an altered outcome of the examination. The second component was related to the pregnant 
Table 4. Analysis of the factorial components of each item obtained by the Varimax Rotation Method. 
Hospital Regional de São José, state of Santa Catarina, Brasil, 2017. (n = 55)
PDPAS Items
Extraction of principal 
components
1 2 3
10 I am afraid there is something wrong with the baby. 0.888
11
I am anxious because I do not know what to do if the results are 
abnormal.
0.868
7 The waiting for the results makes me anxious. 0.847
4 I am worried about the result of the procedure. 0.776
8 The waiting for the procedure is upsetting itself. 0.713
3 I am worried about the procedure itself. 0.646
6 I am afraid of discomfort during the procedure. 0.926
5 I am afraid of pain during the procedure. 0.915
9 I am afraid of miscarriage due to the procedure. 0.754
1 I am afraid that the procedure will harm the baby. 0.693
2 Baby certainly has anomalies. 0.842
PDPAS: Prenatal Diagnostic Procedures Anxiety Scale
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woman’s fear about questions related to the procedure itself. The third, containing only 
item 2, “The baby certainly has anomalies (malformation)”, which brings an already defined 
affirmation to the patient, was not related to the set of remaining items.
The original Croatian PDPAS23 showed the existence of only two dimensions, one related 
to fear of the procedure itself, comprising items 1, 3, 5, 6, 7, 8 and 9, and another to fear 
of abnormal results and concerns about fetal health, covering items 2, 4, 10 and 11. It is 
observed that the items constituting the dimensions of the Croatian instrument differ from 
those presented in the Brazilian version, even when compared to the first two components 
found in the present study.
As for the item 2 of the questionnaire, its permanence in the Brazilian version of the PDPAS 
should be questioned, since it was the only one to express consistency below 0.400, not 
reaching the minimum value to be considered reliable. In addition, item 2 was responsible 
for creating a third component in the questionnaire, presenting a different idea from the 
remaining items. Because it is a question that brings to mind a very limited thought that is 
not related to the anxiety of a diagnosis that is still to come, but rather to something already 
known, it is coherent and timely to propose its withdrawal from the PDPAS instrument in 
its Brazilian version.
Unlike the original study23, which limited patients to those who underwent ultrasonography 
in the second trimester of gestation, this Brazilian version covered all gestational ages and 
types of ultrasonography that can be performed during pregnancy. This difference was 
important to allow the Brazilian instrument to be used in any circumstance where there 
may be anxiety, without the need for alterations.
One limitation of the present study was the difficulty found to test the Brazilian version of 
the PDPAS in two different moments. Since the questionnaire was used with patients from 
the public healthcare network, it was not possible to perform a second application. Thus, 
it was not possible to perform test-retest reliability analysis, which would lead to additional 
knowledge for the research.
This study concluded that the Brazilian version of the PDPAS is reliable and valid, which 
allows its use to consolidate the diagnosis of anxiety during pregnancy, linked to the 
performance of ultrasonographic procedures in the prenatal period, which can either be 
detrimental to the mother as for its concept. There are still no published studies that use 
the PDPAS instrument to assess prenatal anxiety as well as analyze its importance in this 
diagnosis and role in reducing maternal-fetal risks and improving the quality of maternal 
life, but we believe that this can happen when its use is popularized. It is also suggested 
that question 2 be withdrawn from the final version of the instrument, given its lack of 
correlation with the rest of the instrument. Nevertheless, there is a need for further studies 
with other populations and situations in order to observe the behavior of the instrument 
and consolidate its use in Brazil.
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Annex. Final version of the Prenatal Diagnostic Procedures Anxiety Scale questionnaire in Brazilian 
Portuguese.
While waiting for the prenatal diagnostic procedure*, pregnant women have different feelings and thoughts. 
Here are listed some of them. Please read carefully each question and circle the number which best represents 
how often the particular thought occurs to you.
Never or 
rarely
Sometimes Often
Mostly or 
always
1. I am afraid that the procedure will harm the baby. 0 1 2 3
2. Baby certainly has anomalies. 0 1 2 3
3. I am worried about the procedure itself. 0 1 2 3
4. I am worried about the result of the procedure. 0 1 2 3
5. I am afraid of pain during the procedure. 0 1 2 3
6. I am afraid of discomfort during the procedure. 0 1 2 3
7. The waiting for the results makes me anxious. 0 1 2 3
8. The waiting for the procedure is upsetting itself. 0 1 2 3
9. I am afraid of miscarriage due to the procedure. 0 1 2 3
10. I am afraid there is something wrong with the baby. 0 1 2 3
11.
I am anxious because I do not know what to do if the 
results are abnormal. 
0 1 2 3
* If the questionnaire is administered only for the specific prenatal diagnosis procedure, the word 
“procedure”/”postupak” (cro.) can be replaced by the name of the procedure (i.e., amniocentesis, ultrasound...).
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